Another two... [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-17 01:41 (1735 d 08:40 ago) – Posting: # 22575
Views: 23,632

Dear all,

It looks like the FDA has just keelhauled 2 CROs again: Panexcell and Synchron Research. The FDA will reject all data from both CROs due to data manipulation. All Panexcell data had already been rejected in the EU.

The FDA letters are very explicit regarding what they have found, and their conclusion is crystal clear:

Put simply, because you have been responsible for the creation of false data in the studies discussed here, we have no reason to believe that any data that you have produced are reliable. Thus, FDA has determined that all study data from all studies conducted at your firm must be rejected.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
170 visitors (0 registered, 170 guests [including 22 identified bots]).
Forum time: 10:21 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5